Literature DB >> 29956814

E‑cadherin is downregulated by microenvironmental changes in pancreatic cancer and induces EMT.

Weibin Wang1, Liangbo Dong1, Bangbo Zhao1, Jun Lu1, Yupei Zhao1.   

Abstract

The aim of the present study was to research the effect of microenvironmental change on epithelial‑mesenchymal transition (EMT) in pancreatic cancer cells and to determine the correlation between E‑cadherin expression and the prognosis of pancreatic cancer patients. We established hypoxic, serum‑deficient and TGF‑β‑induced microenvironment models of pancreatic cancer cells and studied the changes in the mRNA and protein expression of EMT‑related molecules, E‑cadherin and vimentin, using western blot analysis and real‑time PCR. Furthermore, immunohistochemistry was used to investigate E‑cadherin expression in pancreatic cancer tissues, and survival analysis and COX regression analysis were conducted. In pancreatic cancer cells under hypoxic, serum‑starved and TGF‑β‑induced microenvironments, E‑cadherin protein and mRNA levels were significantly decreased (P<0.05), while vimentin protein and mRNA expression levels were significantly increased (P<0.05). The results of immunohistochemistry showed that the protein level of E‑cadherin in pancreatic cancer tissues was positively correlated with overall survival (P<0.01). The results of Cox regression analysis showed that E‑cadherin was an independent prognostic factor in pancreatic cancer. In conclusion, E‑cadherin expression was significantly decreased by microenvironment changes, and this decrease induced EMT in pancreatic cancer cells. E‑cadherin is an independent prognostic marker in pancreatic cancer patients.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29956814     DOI: 10.3892/or.2018.6528

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

1.  Colorectal cancer stem cell-derived exosomal long intergenic noncoding RNA 01315 (LINC01315) promotes proliferation, migration, and stemness of colorectal cancer cells.

Authors:  Youran Li; Minna Wu; Shanshan Xu; Hua Huang; Lei Yan; Yunfei Gu
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

2.  Elucidation of the mechanism of miR-122-5p in mediating FOXO3 injury and apoptosis of mouse cochlear hair cells induced by hydrogen peroxide.

Authors:  Jiajun Chen; Jixin Qin; Jin Liu
Journal:  Exp Ther Med       Date:  2022-05-09       Impact factor: 2.751

3.  High vimentin expression with E-cadherin expression loss predicts a poor prognosis after resection of grade 1 and 2 pancreatic neuroendocrine tumors.

Authors:  Bo Zhou; Jie Xiang; Ming Jin; Xiang Zheng; Guogang Li; Sheng Yan
Journal:  BMC Cancer       Date:  2021-03-31       Impact factor: 4.430

4.  Prognostic and Clinicopathological Significance of E-Cadherin in Pancreatic Cancer Patients: A Meta-Analysis.

Authors:  Pengbo Wang; Zengkuan Zhu
Journal:  Front Oncol       Date:  2021-04-12       Impact factor: 6.244

5.  18β-Glycyrrhetinic Acid Has Anti-Cancer Effects via Inducing Apoptosis and G2/M Cell Cycle Arrest, and Inhibiting Migration of A549 Lung Cancer Cells.

Authors:  Ying-Hua Luo; Cheng Wang; Wan-Ting Xu; Yu Zhang; Tong Zhang; Hui Xue; Yan-Nan Li; Zhong-Ren Fu; Ying Wang; Cheng-Hao Jin
Journal:  Onco Targets Ther       Date:  2021-10-22       Impact factor: 4.147

6.  Complementary effects of Orthosiphon stamineus standardized ethanolic extract and rosmarinic acid in combination with gemcitabine on pancreatic cancer.

Authors:  Ashwaq H S Yehya; Muhammad Asif; Amin M S Abdul Majid; Chern E Oon
Journal:  Biomed J       Date:  2020-05-28       Impact factor: 4.910

7.  Porcine pancreatic ductal epithelial cells transformed with KRASG12D and SV40T are tumorigenic.

Authors:  Katie L Bailey; Sara B Cartwright; Neesha S Patel; Neeley Remmers; Audrey J Lazenby; Michael A Hollingsworth; Mark A Carlson
Journal:  Sci Rep       Date:  2021-06-28       Impact factor: 4.996

8.  Expression of CYB5D2 is associated with epithelial-mesenchymal transition and survival rates in patients with cervical cancer.

Authors:  Dongxue Li; Bing Qiu; Xiaohang Chen; Liang Hu; Lijuan Wen; Fengxiang Wei
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.